Background: Transhiatal oesophagectomy is associated with peri and postoperative blood loss. This study was aimed to evaluate the clinical efficacy and safety of tranexamic acid in reducing peri and postoperative blood loss in patients undergoing transhiatal oesophagectomy.

Materials and Methods: A total of 64 patients, who underwent elective transhiatal oesophagectomy were studied. They were divided into two groups. In the study group of 40, tranexamic acid 10 mg/kg intravenous was given before starting intra thoracic dissection and the control group did not receive tranexamic acid. Intra and post-operative blood loss, operation time, transfusion of blood products, pre- and post-operative haemoglobin, number of days of hospitalisation and in hospital mortality was studied for both groups.

Results: Tranexamic acid significantly reduced the volume of blood loss during the surgery when compared with the control group. Considering the duration of operation and the treatment groups only, the mean total blood loss in the control group was more than that in the tranexamic acid group. There was no difference in the length of hospital stay between the two groups.

Conclusion: The prophylactic administration of tranexamic acid has effectively reduced the blood loss and transfusion needs during transhiatal oesophagectomy without any adverse effects or complication of thrombosis.

Keywords: Tranexamic acid, blood loss, trans hiatal oesophagectomy.

1. Cap AP, Baer DG, Orman JA, Aden J, Ryan K, Blackbourne LH. Tranexamic acid fortrauma patients: a critical review of the literature. J Trauma. 2011;71(1Suppl):S9-14. Review.
2. Maugans TA, Martin D, Taylor J, Salisbury S, Istaphanous G. Comparative analysis of tranexamic Acid use in minimally invasive versus open craniosynostosis procedures. J Craniofac Surg. 2011;22(5):1772-8.
3. Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V, Woratanarat P, Chanplakorn P, Wibulpolprasert B, et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective tripleblinded randomized controlled trial. Orthop Rev (Pavia). 2011;3(2):e12.
4. Endres S, Heinz M, Wilke A. Efficacy of tranexamic acid in reducing blood loss in posterior lumbar spine surgery for degenerative spinal stenosis with instability: a retrospective case control study. BMC Surg. 2011;11(1):29.
5. Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, CasiraghiGM, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostate-ctomy: double blind, randomised, placebo controlled trial. BMJ. 2011;343:d5701.
6. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;29:236.
7. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. AnesthAnalg. 1997;84:839.
8. Zellin G, Rasmusson L, Palsson J, et al. Evaluation of hemorrhage depressors on blood loss during orthognathic surgery: A retrospective study. J Oral Maxillofac Surg. 2004;62:662.
9. Sethna NF, Zurakowski D, Brustowicz RM, et al. Tranexamic acid reduces intraop-erative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102:727.
10. Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranex-amic acid. Anesthesiology. 1995;82:383.
11. Eriksson O, Kjellman H, Pilbrant A, et al. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J ClinPharmacol. 1974;7:375.
12. Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J ClinPharmacol. 1981;20:65.

Dr Nadeem Ul Nazeer

Post MCh Senior Resident, Department of CVTS, SKIMS, Soura, Srinagar, 190011, India

Mob no 9419516738, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.